Mr. Zhiwei He is the CEO of Nanland Investment Fund Management (Beijing) Co., Ltd., a private equity fund company which investments in the fields of biotechnology and advanced equipment manufacturing. At Nanland, Mr. He is the Managing Director of the Jiuzhitang Yonghe Qihang Fund. Mr. He also serves as the Assistant to the Chairman of Jiuzhitang Group Co. (Beijing) Ltd., a pharmaceutical public company in established in the year 1650 in China.
Mr. He posses a strong background with a masters in Finance from the University of International Business and Economics (Beijing). Mr. He has been working in the science technology field for over 10 years for public companies with between with between $2-$8 Billion USD market cap values such as Goldwind Science Technology Co. Ltd. and ORG Science Technology Co. working in the areas of M&A and strategic investments.